ORBITAL THERAPEUTICS Trademark

Trademark Overview

On Wednesday, June 29, 2022, a trademark application was filed for ORBITAL THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ORBITAL THERAPEUTICS trademark a serial number of 97482263. The federal status of this trademark filing is REGISTERED as of Tuesday, February 25, 2025. This trademark is owned by Orbital Therapeutics, Inc.. The ORBITAL THERAPEUTICS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing medical information in the fields of health, medicine, biotechnology, biologics, biosimilars, pharmaceuticals, vaccines, and therapeutics related to genetic science, genomics, gene expression, protein-encoding nucleic acids or polypeptide-encoding nucleic acids
orbital therapeutics

General Information

Serial Number97482263
Word MarkORBITAL THERAPEUTICS
Filing DateWednesday, June 29, 2022
Status700 - REGISTERED
Status DateTuesday, February 25, 2025
Registration Number7706969
Registration DateTuesday, February 25, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 29, 2023

Trademark Statements

Goods and ServicesProviding medical information in the fields of health, medicine, biotechnology, biologics, biosimilars, pharmaceuticals, vaccines, and therapeutics related to genetic science, genomics, gene expression, protein-encoding nucleic acids or polypeptide-encoding nucleic acids
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 5, 2022
Primary Code044
First Use Anywhere DateWednesday, August 31, 2022
First Use In Commerce DateWednesday, August 31, 2022

Trademark Owner History

Party NameOrbital Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameOrbital Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameOrbital Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Saturday, July 2, 2022NEW APPLICATION ENTERED
Tuesday, July 5, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 5, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 5, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 5, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 12, 2023ASSIGNED TO EXAMINER
Wednesday, April 19, 2023NON-FINAL ACTION WRITTEN
Wednesday, April 19, 2023NON-FINAL ACTION E-MAILED
Wednesday, April 19, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 18, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 18, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 25, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 9, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 29, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 29, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 18, 2024SOU EXTENSION 1 GRANTED
Monday, March 18, 2024SOU EXTENSION 1 FILED
Thursday, April 25, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 18, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 25, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 25, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 25, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 25, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 24, 2024TEAS STATEMENT OF USE RECEIVED
Friday, May 24, 2024USE AMENDMENT FILED
Tuesday, July 2, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 23, 2024SU - NON-FINAL ACTION - WRITTEN
Tuesday, July 23, 2024NON-FINAL ACTION E-MAILED
Tuesday, October 15, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, July 2, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 15, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, January 29, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 29, 2025ASSIGNED TO LIE
Wednesday, February 5, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 5, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 25, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, February 25, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, January 23, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 29, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE

Related Keywords

therapeutics orbital encoding acids nucleic genomics science genetic gene protein polypeptide related